AI-powered search
AI-powered search

Live Evaluations

Optimizing The Patient Skin Cancer Journey With Gene Expression Profiling

About

Optimizing The Patient Skin Cancer Journey With Gene Expression Profiling

This activity is supported by an educational grant from Castle Biosciences.

Learning Objectives

At the completion of this activity, participants should be better able to:

  • Discuss the role of gene expression profiling for the management of skin cancers

  • Describe how to integrate gene expression profiling for cutaneous melanoma and SCC to inform risk- and appropriate management decisions

Intended Audience
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
Faculty
Laura
Laura Ferris, MD, PhD

Professor and Director of Clinical Trials, Dermatology
University of Pittsburgh
Pittsburgh, PA

Darrell
Darrell Rigel, MD, MS

Clinical Professor of Dermatology 
New York University
Grossman School of Medicine
New York, NY 
Adjunct Professor
UT Southwestern Medical School 
Consultant Dermatologist, Cooper Clinic
Dallas, TX

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures & Disclaimers

Disclosures are as follows:

Laura K. Ferris, MD, PhD

Advisory Board: DermTech, Boerhinger-Ingelheim, AbbVie, Bristol-Myers Squibb, Arcutis, Dermavant, Cara Therapeutics, Leo Pharma, Regeneron, Amgen, Janssen, Novartis Grant/Research Support: AbbVie, Bristol-Myers Squibb, DermTech, Castle Biosciences, Arcutis, Amgen, Janssen, Eli Lilly, Novartis, UCB, Moberg, Aristea, Acelyrin, Cara Therapeutics, Leo Pharma, Regeneron, SkinAnalytics Consultant: DermTech, Boerhinger-Ingelheim, AbbVie, Bristol-Myers Squibb, Arcutis, Dermavant, Cara Therapeutics, Leo Pharma, Pfizer, Regeneron, Amgen, Janssen, Novartis, Sanofi Speakers’ Bureau or Honoraria: Boerhinger-Ingelheim, Bristol-Myers Squibb, Arcutis, Regeneron, Abbvie

Darrell S. Rigel, MD, MS

Grant/Research Support: Castle Biosciences, SciBASE

Consultant: DermTech, Ferndale Laboratories, Inc., SciBase, VYNE Therapeutics 

Speakers’ Bureau or Honoraria: Castle Biosciences

Advisory Board: Almirall, Beiersdorf, Inc., Castle Biosciences, Johnson and Johnson 

The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.


Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved